[Treatment of myelodysplastic syndromes aside from clinical studies].
Lengfelder
E
E
III. Medizinische Klinik, Klinikum Mannheim, Universität Heidelberg.
Hehlmann
R
R
D000367:Age Factors; D000368:Aged; D003613:Danazol / Q000627:therapeutic use; D017707:Erythrocyte Transfusion; D004965:Estrogen Antagonists / Q000627:therapeutic use; D005260:Female; D006801:Humans; D009190:Myelodysplastic Syndromes / Q000401:mortality / Q000628:therapy*; D017713:Platelet Transfusion; D011379:Prognosis; D011736:Pyridoxine / Q000627:therapeutic use
D004965:Estrogen Antagonists; D011736:Pyridoxine; D003613:Danazol
Behandlung myelodysplastischer Syndrome ausserhalb klinischer Studien.